Kinnari Patel, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 7,978 shares at $18.50 ($148K) on 2024-08-16, disclosed to the SEC on 2024-08-20.
Open-market sale of $148k RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.50 | 3,989 | $74K | 50.0% |
| 2 | $18.50 | 3,989 | $74K | 50.0% |
| Total | $18.50 avg | 7,978 | $148K | 100% |
| Filing → |
| RCKT | BUY | 2025-04-10 | $198K | — | Filing → |
| RCKT | SELL | 2025-02-25 | $129K | — | Filing → |
| RCKT | SELL | 2024-11-25 | $120K | — | Filing → |